We are live on ! Find out more
SBFMW icon

Sunshine Biopharma Warrant
SBFMW

1 hedge funds and large institutions have $1.79K invested in Sunshine Biopharma Warrant in 2026 Q1 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.05% more ownership

Funds ownership: 0.73% → 0.78% (+0.05%)

0% more funds holding

Funds holding: 1 → 1 (0)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$197

Top Sellers

No sellers this quarter

SBFMW Hedge Fund Activity: Q1 2026 in Review

1 of the 8,244 institutional investors tracked by Wall St. Rank reported a position in Sunshine Biopharma Warrant (SBFMW) for Q1 2026, worth a combined $1.79K — down 39% from $2.94K a quarter earlier.

Fund positioning in SBFMW was balanced in Q1 2026: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was UBS Group, adding an estimated $197.

  • 1 institutional investor held Sunshine Biopharma Warrant (SBFMW) as of Q1 2026, unchanged from Q4 2025.
  • Funds reported $1.79K of Sunshine Biopharma Warrant stock for Q1 2026, down 39% quarter-over-quarter.
  • 0 funds opened new Sunshine Biopharma Warrant positions in Q1 2026 and 0 closed out.
  • The largest Sunshine Biopharma Warrant buyer in Q1 2026 was UBS Group, an estimated $197 added.

Based on aggregated 13F filings for Q1 2026.